Instil Bio, Inc. financial data

Symbol
TIL on Nasdaq
Location
3963 Maple Avenue, Suite 350, Dallas, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.16K % +50.3%
Debt-to-equity 66.6 % +35.1%
Return On Equity -53 % -41.6%
Return On Assets -31.8 % -26.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.78M shares +3.92%
Common Stock, Shares, Outstanding 6.78M shares +3.93%
Entity Public Float 38.6M USD +12.2%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.76M shares +3.86%
Weighted Average Number of Shares Outstanding, Diluted 6.76M shares +3.86%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 20.7M USD -76.9%
General and Administrative Expense 31.5M USD -29.5%
Operating Income (Loss) -80.8M USD -8.17%
Nonoperating Income (Expense) -929K USD +47.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -156M USD +30.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -75.1M USD +0.12%
Earnings Per Share, Basic -11 USD/shares +1.47%
Earnings Per Share, Diluted -11 USD/shares +1.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.8M USD -12.9%
Marketable Securities, Current 141M USD -35%
Other Assets, Current 164K USD -91.6%
Assets, Current 196M USD +48%
Property, Plant and Equipment, Net 138M USD +6.03%
Operating Lease, Right-of-Use Asset 415K USD -62.4%
Other Assets, Noncurrent 4.15M USD -32.9%
Assets 212M USD -22.3%
Accounts Payable, Current 928K USD -22.3%
Employee-related Liabilities, Current 2.09M USD -13.2%
Liabilities, Current 5.7M USD -44.6%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 88K USD +1000%
Liabilities 91.3M USD -5.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax -612K USD -17.7%
Retained Earnings (Accumulated Deficit) -718M USD -11.7%
Stockholders' Equity Attributable to Parent 120M USD -31.7%
Liabilities and Equity 212M USD -22.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.2M USD +70.9%
Net Cash Provided by (Used in) Financing Activities 232K USD
Net Cash Provided by (Used in) Investing Activities 9.61M USD +3.98%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 6.78M shares +3.93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.08M USD -8.74%
Interest Paid, Excluding Capitalized Interest, Operating Activities 886K USD -48.8%
Deferred Tax Assets, Valuation Allowance 141M USD +11.6%
Deferred Tax Assets, Gross 143M USD +12.6%
Operating Lease, Liability 305K USD -90.4%
Depreciation 1.21M USD -69%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.2M USD -0.01%
Lessee, Operating Lease, Liability, to be Paid 315K USD -91.1%
Property, Plant and Equipment, Gross 509K USD -99.6%
Operating Lease, Liability, Current 305K USD -82.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year One 170K USD -89.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10K USD -97.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.82M USD +43.1%
Deferred Tax Assets, Operating Loss Carryforwards 95.8M USD +8.33%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.34M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD -4.17%
Operating Lease, Payments 1.6M USD -29%
Additional Paid in Capital 839M USD +2.35%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 498K USD -49.8%
Deferred Tax Assets, Net of Valuation Allowance 1.19M USD
Share-based Payment Arrangement, Expense 11.6M USD -33.1%
Interest Expense 6.55M USD +160%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%